Mast Cell Activation and Dysbiosis
9th November 2021
Functional gastrointestinal (GI) disorders such as irritable bowel syndrome and functional dyspepsia are thought to affect at least 15% of the general population. Mast cell activation and dysbiosis are among the leading pathophysiological processes that have been implicated in functional GI disorders featuring common symptoms such as bloating, abdominal pain, and altered bowel habits.
Advanced stool testing with quantitative PCR (qPCR) can provide important insights into overall gut health, as well as specific factors that may be involved in functional GI disorders.
Join Dr. Fabian on October 20, 2021, at 2 PM ET as he discusses how GI-MAP stool testing can provide clinicians with critical insights into specific microbes, dysbiosis patterns, and GI imbalances that may contribute to mast cell activation and related symptoms in patients with functional GI disorders.
This live webinar has ended. Please CLICK HERE to access the webinar recording.